THE AFFILIATED HOSPITAL OF QINGDAO UNIVERSITY
🇨🇳China
A Clinical Study of SSS40 in Healthy Chinese Volunteers
- First Posted Date
- 2023-09-05
- Last Posted Date
- 2023-09-05
- Lead Sponsor
- The Affiliated Hospital of Qingdao University
- Target Recruit Count
- 69
- Registration Number
- NCT06022536
A First-in-human Study of a Novel Recombinant Humanized Anti-interleukin-6 Receptor Monoclonal Antibody
- First Posted Date
- 2023-09-01
- Last Posted Date
- 2023-09-01
- Lead Sponsor
- The Affiliated Hospital of Qingdao University
- Target Recruit Count
- 40
- Registration Number
- NCT06021574
- Locations
- 🇨🇳
the Affliated Hospital of Qingdao University, Qingdao, Shandong, China
A Clinical Study of BG136 Injection in Healthy Chinese Volunteers
- First Posted Date
- 2023-08-09
- Last Posted Date
- 2023-08-30
- Lead Sponsor
- The Affiliated Hospital of Qingdao University
- Target Recruit Count
- 74
- Registration Number
- NCT05984368
- Locations
- 🇨🇳
Affiliated Hospital of Qingdao University Phase I Clinical Research Center, Qingdao, Shandong, China
Bioequivalence Study of Entacapone,Levodopa and Carbidopa Tablets in Healthy Chinese Subjects
Phase 1
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-08-04
- Last Posted Date
- 2023-08-04
- Lead Sponsor
- The Affiliated Hospital of Qingdao University
- Target Recruit Count
- 68
- Registration Number
- NCT05976737
Bioequivalence Study of Empagliflozin And Linagliptin Tablets in Healthy Chinese Subjects
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2023-07-21
- Last Posted Date
- 2023-07-21
- Lead Sponsor
- The Affiliated Hospital of Qingdao University
- Target Recruit Count
- 106
- Registration Number
- NCT05956522
- Locations
- 🇨🇳
The Affiliated Hospital of Qingdao University Phase I Clinical Research Center, Qingdao, Shandong, China
Exploratory Clinical Trial on the Safety, Efficacy, and Pharmacokinetics of XKDCT086 (iPD-1-Claudin18.2-CAR-T) in Claudin 18.2 Positive Advanced Solid Malignant Tumors: a Single Center, Single Arm, Dose-increasing Trial
Not Applicable
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-07-19
- Last Posted Date
- 2023-07-19
- Lead Sponsor
- The Affiliated Hospital of Qingdao University
- Target Recruit Count
- 9
- Registration Number
- NCT05952375
- Locations
- 🇨🇳
The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China
Effect of Probiotic Supplements on Gastric Cancer Patients Receiving Neoadjuvant Chemotherapy
Not Applicable
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-06-13
- Last Posted Date
- 2023-06-13
- Lead Sponsor
- The Affiliated Hospital of Qingdao University
- Target Recruit Count
- 318
- Registration Number
- NCT05901779
- Locations
- 🇨🇳
Department of Gastrointestinal Surgery, Qingdao University Affiliated Hospital, Qingdao, Shandong, China
XKDCT080 in GCC-positive Recurrent or Refractory Solid Tumors With Single Center, Single Arm, and Dose Escalation
Not Applicable
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-05-25
- Last Posted Date
- 2023-05-25
- Lead Sponsor
- The Affiliated Hospital of Qingdao University
- Target Recruit Count
- 9
- Registration Number
- NCT05875402
- Locations
- 🇨🇳
The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China
Laparoscopic Gastrectomy With D2 Lymphadenectomy Combined With Hyperthermic Intraperitoneal Chemotherapy (HIPEC) or Not
Phase 3
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-05-23
- Last Posted Date
- 2023-05-23
- Lead Sponsor
- The Affiliated Hospital of Qingdao University
- Target Recruit Count
- 616
- Registration Number
- NCT05871099
- Locations
- 🇨🇳
The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China
Bioequivalence Study of Apixaban Tablets in Healthy Chinese Subjects
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2023-05-03
- Last Posted Date
- 2023-05-03
- Lead Sponsor
- The Affiliated Hospital of Qingdao University
- Target Recruit Count
- 54
- Registration Number
- NCT05841446
- Locations
- 🇨🇳
The Affiliated Hospital of Qingdao University Phase I Clinical Research Center, Qingdao, Shandong, China
© Copyright 2024. All Rights Reserved by MedPath